Is it time for oncologists to modify their laissez-faire attitude toward alternative/ complementary ‘drug therapy’? Maurie Markman Editor’s Commentary Pages: 1 - 2
Central nervous system toxicity from cancer treatment Terri ArmstrongMark R. Gilbert OriginalPaper Pages: 11 - 19
A role for antiangiogenic therapy in breast cancer Marsha A. MosesJay HarperCecilia A. Fernández OriginalPaper Pages: 42 - 48
Management of patients with locally advanced breast cancer Lisa A. Newman OriginalPaper Pages: 53 - 61
The role of positron emission tomographic imaging in breast cancer Michelle D. McDonoughElizabeth R. DePeriBetty A. Mincey OriginalPaper Pages: 62 - 68
Ductal lavage in the screening of high-risk women Patrick J. KenneyMargarett C. Ellison OriginalPaper Pages: 69 - 73
Letrozole in postmenopausal women after five years on tamoxifen Edith A. Perez Clinical Trials Report Pages: 74 - 74